betagenon ab

Private Company

Company Profile

Sector: Health Care
Industry: Biotech & Pharma
Sub-Industry: Biotech
Betagenon AB operates as a biotechnology company. The Company develops novel, safe, and effective therapies for treatment of obesity-related disorders including type 2 diabetes, fatty liver, disorders linked to hyperinsulinemia, and various forms of cancer. Betagenon provides treatments for patients in Sweden.

Corporate Information

Stora Nygatan 20
Stockholm, 103 18
Fax: -

From The Web

Sponsored Financial Commentaries

More From The Web